During the past decade, North Shore-LIJ Hearing and Speech Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Shore-LIJ Hearing and Speech Center" #1 collaborator was "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 1 trials as a collaborator and "Swedish Orphan Biovitrum" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "North Shore-LIJ Hearing and Speech Center" are "Autoimmune Inner Ear Disease" (2 trials), "Hearing Loss, Sudden" (1 trials), "Sensorineural Hearing Loss" (1 trials) and "Tinnitus, Subjective" (1 trials). Many other conditions were trialed in "North Shore-LIJ Hearing and Speech Center" in a lesser frequency.

Most popular intervention types in "North Shore-LIJ Hearing and Speech Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Anakinra" (1 trials), "Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)" (1 trials), "Anakinra 100Mg/0.67Ml Inj Syringe (Period 2)" (1 trials), "OTO-313" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Shore-LIJ Hearing and Speech Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "North Shore-LIJ Hearing and Speech Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in North Shore-LIJ Hearing and Speech Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in North Shore-LIJ Hearing and Speech Center, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".